DIM — Sartorius Stedim Biotech SA Cashflow Statement
0.000.00%
Last trade - 00:00- €18.49bn
- €20.98bn
- €2.78bn
Annual cashflow statement for Sartorius Stedim Biotech SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 317 | 483 | 647 | 1,130 | 401 |
| Depreciation | |||||
| Non-Cash Items | 14.9 | -9.77 | 220 | -133 | 49.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -95.5 | -158 | -307 | -567 | 57.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 310 | 417 | 702 | 612 | 746 |
| Capital Expenditures | -136 | -159 | -324 | -431 | -474 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -48.4 | -462 | -141 | -527 | -2,249 |
| Acquisition of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -184 | -621 | -465 | -958 | -2,723 |
| Financing Cash Flow Items | -9.78 | -34.1 | -9.5 | -52.4 | -205 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -122 | 234 | -77.7 | 221 | 1,986 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.19 | 31.6 | 164 | -117 | 9.5 |